BC classification is primarily based on the expression levels of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), allowing us to identify groups of breast tumors with distinct characteristics in terms of proliferation, mutated genes, and invasive potential [5]. This evidence concerns the gene ERBB2 and breast cancer.